People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Genialis, Inc. | — | Biotechnology | Series A | $12.1M | $1.8M | 2023 |
Hamzeh Krisper Abdul-Hadi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Hamzeh Krisper Abdul-Hadi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Krista McKerracher | 1 | 2 |
| Cedric Hermann Odje | 1 | 1 |
| Elia Hermann Stupka | 1 | 1 |
| Miha Stajdohar | 1 | 1 |
| Rafael Rosengarten | 1 | 1 |
| Luka Ausec | 1 | 1 |
| Nadine Krisper Geiser | 1 | 1 |
| Elia Krisper Stupka | 1 | 1 |
| Ita Krisper Lu | 1 | 1 |
| Luka Krisper Ausec | 1 | 1 |
| Drew Krisper Volpe | 1 | 1 |
| Ita Lu | 1 | 1 |
| Tjasa Krisper Kutin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.